Logo Logo
Switch Language to German

Luo, Dong; Liu, Yunfei; Yuan, Shuai; Bi, Xianyun; Yang, Yongchao; Zhu, Hongwei; Li, Zhiqiang; Ji, LianDong and Yu, Xiao (2022): The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer. In: Pathology, Research and Practice, Vol. 235, 153938

Full text not available from 'Open Access LMU'.


Long noncoding RNAs (lncRNAs) are transcripts of more than 200 nucleotides that lack the ability to encode protein. Convincing studies have indicated that lncRNAs can act as oncogenes or tumor suppressors by regulating gene expression. The novel lncRNA NR2F1-AS1 was recently found to be abnormally expressed in various malignancies, including hepatocellular carcinoma, gastric cancer, colorectal cancer, pancreatic cancer, breast cancer, lung cancer, thyroid cancer, esophageal squamous cell carcinoma, osteosarcoma, and neuroblastoma. NR2F1-AS1 can modify cell proliferation, invasion, migration, apoptosis, the cell cycle, and glycolysis through various mechanisms involving direct or indirect effects on pathways. Furthermore, NR2F1-AS1 may be a potential therapeutic target and prognostic marker in cancer, as it has been related to the clinicopathological characteristics of cancer patients. Here, we summarize and clarify recent research advances regarding the expression, function, molecular mechanisms, and clinical implications of NR2F1-AS1 in multiple malignant tumors.

Actions (login required)

View Item View Item